Jamunarani Veeraraghavan

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Endoplasmic Reticulum

Positive Breast Cancer

Epidermal Growth Factor Receptor

Top Venues

NPJ breast cancer

Nature reviews. Clinical oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Jamunarani Veeraraghavan, Carolina Gutierrez, Carmine De Angelis, Robert Davis, Nicholas Wang, Tomás Pascual, Pier Selenica, Katherine Sanchez, Hiroaki Nitta, Monesh Kapadia, Anne C Pavlick, Patricia Galván, Brent N Rexer, Andres Forero-Torres, Rita Nanda, Anna Maria V Storniolo, Ian E Krop, Matthew P Goetz, Julie R Nangia, Antonio C Wolff, Jorge S Reis-Filho, Jorge Sergio Reis-Filho, Susan G Hilsenbeck, Aleix Prat, C Kent Osborne, Rachel Schiff, Mothaffar F Rimawi
A multiparameter molecular classifier to predict response to neoadjuvant lapatinib plus trastuzumab without chemotherapy in HER2+ breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jamunarani Veeraraghavan, Carolina Gutierrez, Vidyalakshmi Sethunath, Sepideh Mehravaran, Mario Giuliano, Martin J Shea, Tamika Mitchell, Nicholas Wang, Sarmistha Nanda, Resel Pereira, Robert Davis, Kristina Goutsouliak, Lanfang Qin, Carmine De Angelis, Irmina Diala, Alshad S Lalani, Chandandeep Nagi, Susan G Hilsenbeck, Mothaffar F Rimawi, C Kent Osborne, Rachel Schiff
Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models. NPJ breast cancer 7 (1) (2021)
Kristina Goutsouliak, Jamunarani Veeraraghavan, Vidyalakshmi Sethunath, Carmine De Angelis, C Kent Osborne, Mothaffar F Rimawi, Rachel Schiff
Towards personalized treatment for early stage HER2-positive breast cancer. Nature reviews. Clinical oncology 17 (4) (2019)